MarketInOut Stock Screener Log In | Sign Up
 

AbbVie Inc

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 08/03/2026 16:00
AbbVie Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization443,359 mln
Float1,764 mln
Earnings Date07/31/2026

EPS

3.54
Stretched

P / E

69.24
Richly valued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.68
Likely reliable

1-Year Forecast

270
Modest upside

Relative Strength

12 / 100
Significantly lagging

Business Description

AbbVie is a global pharmaceutical company founded in 2012 and based in North Chicago, Illinois, that develops and sells treatments across a wide range of medical conditions. Its portfolio includes medicines for blood cancers, autoimmune and inflammatory diseases, neurological disorders, migraines, and eye conditions, as well as therapies for hepatitis C and digestive health. The company also has a strong presence in aesthetics, offering products such as Botox and the Juvederm collection for cosmetic and skin-related treatments.

Key Fundamentals

EPS3.54
P/E69.24
RPS36.33
ROIC14.04
ROA4.66
Interest Cover7.87
EBITDA, mln15,526
EV / EBITDA32.65
EV / EBIT44.17
Revenue, mln64,386
EV / Revenue7.87

Financial Strength

Altman Z-Score2.27
Piotroski F-Score 5 / 9
Beneish M-Score-2.68
Price to Intrinsic Value2.46
1-Year Target Price270
Shiller PE Ratio53.45
Short Ratio2.42
Short % of Float1.42

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.6% 7 / 100   
1 Month -5.45% 14 / 100   
2 Months 24.22% 93 / 100   
6 Months 11.61% 74 / 100   
1 Year 33.64% 79 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us